Tag: immunotherapy

Search News
Categories
Archives
CRUK Career Establishment Award

4th July 2019

Dr Oliver Pearce has received a Cancer Research UK Career Establishment Award, which will fund a project that will look at restoring response to immunotherapy in triple-negative breast cancer.

Read more

New phase III clinical trial using combination therapy extends survival in triple-negative breast cancer

22nd October 2018

Research provides new hope for people with an aggressive type of breast cancer.

Read more

Immunotherapy shows promise for patients with metastatic triple-negative breast cancer

17th October 2018

Immunotherapy has been shown to confer an encouraging survival benefit in patients with metastatic triple-negative breast cancer (mTNBC).

Read more

Blood Cancer Awareness Month 2018

28th September 2018

Blood Cancer Awareness Month takes place every September to raise awareness of the challenges faced by those living with blood cancer. In the UK, blood cancer is the fifth most common cancer, with 240,000 people living with the disease and 38,000 people being diagnosed with a type of blood cancer each year.

Read more

Pancreatic Cancer UK Grand Challenge

27th July 2018

Our Director, Prof Nicholas Lemoine, and a team of researchers from the BCI and King’s College London have been awarded the Pancreatic Cancer UK (PCUK) Grand Challenge- PCUK’s largest ever research fund. The grant will be used for the development of a type of immunotherapy, known as CAR T cell therapy, to treat pancreatic cancer. Leanne Reynolds, Head of Research at PCUK […]

Read more

London Pancreas Workshop 2018

11th May 2018

On Friday 4th May, BCI hosted the seventh London Pancreas Workshop, co-organised by Prof Hemant Kocher and our Director Prof Nick Lemoine, which attracted delegates from across Europe and America, with over 140 attendees in total. The biennial event is recognised as a forum for state-of-the-art clinical and basic research in pancreatic cancer.

Read more

Search News
Categories
Archives